Literature DB >> 20438382

Similar T-cell immune responses induced by group M consensus env immunogens with wild-type or minimum consensus variable regions.

E A Weaver1, Z T Camacho, F Gao.   

Abstract

Consensus HIV-1 genes can decrease the genetic distances between candidate immunogens and field virus strains. To ensure the functionality and optimal presentation of immunologic epitopes, we generated two group-M consensus env genes that contain variable regions either from a wild-type B/C recombinant virus isolate (CON6) or minimal consensus elements (CON-S) in the V1, V2, V4, and V5 regions. C57BL/6 and BALB/c mice were primed twice with CON6, CON-S, and subtype control (92UG37_A and HXB2/Bal_B) DNA and boosted with recombinant vaccinia virus (rVV). Mean antibody titers against 92UG37_A, 89.6_B, 96ZM651_C, CON6, and CON-S Env protein were determined. Both CON6 and CON-S induced higher mean antibody titers against several of the proteins, as compared with the subtype controls. However, no significant differences were found in mean antibody titers in animals immunized with CON6 or CON-S. Cellular immune responses were measured by using five complete Env overlapping peptide sets: subtype A (92UG37_A), subtype B (MN_B, 89.6_B and SF162_B), and subtype C (Chn19_C). The intensity of the induced cellular responses was measured by using pooled Env peptides; T-cell epitopes were identified by using matrix peptide pools and individual peptides. No significant differences in T-cell immune-response intensities were noted between CON6 and CON-S immunized BALB/c and C57BL/6 mice. In BALB/c mice, 10 and eight nonoverlapping T-cell epitopes were identified in CON6 and CON-S, whereas eight epitopes were identified in 92UG37_A and HXB2/BAL_B. In C57BL/6 mice, nine and six nonoverlapping T-cell epitopes were identified after immunization with CON6 and CON-S, respectively, whereas only four and three were identified in 92UG37_A and HXB2/BAL_B, respectively. When combined together from both mouse strains, 18 epitopes were identified. The group M artificial consensus env genes, CON6 and CON-S, were equally immunogenic in breadth and intensity for inducing humoral and cellular immune responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438382      PMCID: PMC2933159          DOI: 10.1089/aid.2009.0258

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  48 in total

1.  Timing the ancestor of the HIV-1 pandemic strains.

Authors:  B Korber; M Muldoon; J Theiler; F Gao; R Gupta; A Lapedes; B H Hahn; S Wolinsky; T Bhattacharya
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

2.  Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.

Authors:  J R Mascola; G Stiegler; T C VanCott; H Katinger; C B Carpenter; C E Hanson; H Beary; D Hayes; S S Frankel; D L Birx; M G Lewis
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

3.  Increased genetic diversity and intersubtype recombinants of HIV-1 in blood donors from urban Cameroon.

Authors:  Ana Machuca; Shixing Tang; Jinjie Hu; Sherwin Lee; Owen Wood; Christopher Vockley; Suresh Gupta Vutukuri; Ranjana Deshmukh; Bih Awazi; Indira Hewlett
Journal:  J Acquir Immune Defic Syndr       Date:  2007-07-01       Impact factor: 3.731

4.  Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine.

Authors:  Andrew T Catanzaro; Mario Roederer; Richard A Koup; Robert T Bailer; Mary E Enama; Martha C Nason; Julie E Martin; Steve Rucker; Charla A Andrews; Phillip L Gomez; John R Mascola; Gary J Nabel; Barney S Graham
Journal:  Vaccine       Date:  2007-03-07       Impact factor: 3.641

5.  Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV.

Authors:  Anne S De Groot; Daniel S Rivera; Julie A McMurry; Soren Buus; William Martin
Journal:  Vaccine       Date:  2007-12-26       Impact factor: 3.641

6.  A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys.

Authors:  Sampa Santra; Bette T Korber; Mark Muldoon; Dan H Barouch; Gary J Nabel; Feng Gao; Beatrice H Hahn; Barton F Haynes; Norman L Letvin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-23       Impact factor: 11.205

Review 7.  Cytotoxic T lymphocytes specific for the simian immunodeficiency virus.

Authors:  N L Letvin; J E Schmitz; H L Jordan; A Seth; V M Hirsch; K A Reimann; M J Kuroda
Journal:  Immunol Rev       Date:  1999-08       Impact factor: 12.988

8.  Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.

Authors:  T M Allen; D H O'Connor; P Jing; J L Dzuris; B R Mothé; T U Vogel; E Dunphy; M E Liebl; C Emerson; N Wilson; K J Kunstman; X Wang; D B Allison; A L Hughes; R C Desrosiers; J D Altman; S M Wolinsky; A Sette; D I Watkins
Journal:  Nature       Date:  2000-09-21       Impact factor: 49.962

9.  Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination.

Authors:  Wing-Pui Kong; Lan Wu; Timothy C Wallstrom; Will Fischer; Zhi-Yong Yang; Sung-Youl Ko; Norman L Letvin; Barton F Haynes; Beatrice H Hahn; Bette Korber; Gary J Nabel
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

10.  Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

Authors:  K J Metzner; X Jin; F V Lee; A Gettie; D E Bauer; M Di Mascio; A S Perelson; P A Marx; D D Ho; L G Kostrikis; R I Connor
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  6 in total

1.  DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.

Authors:  Mingshun Zhang; Lu Zhang; Chunhua Zhang; Kunxue Hong; Yiming Shao; Zuhu Huang; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2012-10-30       Impact factor: 3.452

Review 2.  Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.

Authors:  Marcel Tongo; Wendy A Burgers
Journal:  Viruses       Date:  2014-10-23       Impact factor: 5.048

3.  Detailed characterization of antibody responses against HIV-1 group M consensus gp120 in rabbits.

Authors:  Yali Qin; Heliang Shi; Saikat Banerjee; Aditi Agrawal; Marisa Banasik; Michael W Cho
Journal:  Retrovirology       Date:  2014-12-20       Impact factor: 4.602

4.  Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Chong Liu; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

5.  Centralized Consensus Hemagglutinin Genes Induce Protective Immunity against H1, H3 and H5 Influenza Viruses.

Authors:  Richard J Webby; Eric A Weaver
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

6.  Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine.

Authors:  Amy Lingel; Brianna L Bullard; Eric A Weaver
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.